In vitro biopharmaceutical evaluation of solid dosage forms containing doxycycline
DOI:
https://doi.org/10.1590/S1516-93322005000400007Keywords:
oxycycline, Biopharmaceutics, Dissolution kinetics, Bioequivalence, Generic drug productsAbstract
The process of drug absorption from solid dosage forms following oral administration depends on drug delivery from dosage form, its dissolution in gastrointestinal conditions and permeation through the intestinal membrane. Therefore, in vitro dissolution is very important to predict the in vivo performance of a drug contained in a solid dosage form. The purpose of this study was to perform an in vitro biopharmaceutical evaluation, through physicochemical, dissolution kinetics and dissolution efficacy tests of four batches of two commercial products available in the Brazilian market, containing 100 mg of doxycycline. The dissolution method described in the United States Pharmacopeia (USP) was used for the dissolution kinetics analysis. It was evaluated by the parameters k s (dissolution rate constant), t50% (time to promote the dissolution of 50% of the drug in the pharmaceutical dosage form) and dissolution efficacy. According to the results it was verified that all the batches were in accordance with official specifications for average weight, doxyxycline content, uniformity content, and dissolution tests. All produtcts showed first order dissolution kinetics. Dissolution efficacy values ranged from 58,48% to 78,39%.Downloads
Download data is not yet available.
Downloads
Published
2005-12-01
Issue
Section
Original Papers
How to Cite
In vitro biopharmaceutical evaluation of solid dosage forms containing doxycycline. (2005). Revista Brasileira De Ciências Farmacêuticas, 41(4), 451-548. https://doi.org/10.1590/S1516-93322005000400007